Key points:
·New Product Launch: PMI Korea releases the limited-edition "Leaf Green" colorway for the IQOS ILUMA i and ILUMA i ONE.
·Availability: Pre-orders begin September 4th at nine IQOS stores nationwide and the official online store.
·Pricing: The ILUMA i is priced at 89,000 KRW (approximately US$64), and the ILUMA i ONE is priced at 59,000 KRW (approximately US$42).
·Design Strategy: Following "Breeze Blue" and "Digital Purple," these new colors enhance design competitiveness and meet diverse consumer needs.
According to Sentv, on September 5, 2025, Philip Morris International (PMI) Korea announced the release of the new "Leaf Green" color for their HNB tobacco device series "IQOS ILUMA i". This new color will first be available for the IQOS ILUMA i and IQOS ILUMA i ONE products.
Philip Morris International (PMI) states that IQOS is meeting consumer preferences by enhancing its design competitiveness. Following the existing colors such as Stellar Blue and Brilliant Purple, the addition of the new Leaf Green color further enriches the product's color lineup.
Starting from September 4th, the new "Leaf Green" products will be available for pre-order through 9 IQOS direct stores and the official online store in Korea. The price of IQOS ILUMA i Leaf Green is 89,000 Korean Won (approximately $68 USD), while the price of IQOS ILUMA i ONE Leaf Green is 59,000 Korean Won (approximately $45 USD).
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
